Stock Events

Stock Events

Kymera Therapeutics (KYMR) Q3 2025 Earnings

11AugConfirmed

Q4 2024

Q1 2025

Q2 2025

Q3 2025

-0.95

-0.89

-0.83

-0.77

Details

Expected EPS

-0.810038

Actual EPS

-0.95

Surprise EPS

-0.14

Surprise Percent

+17.28%

Description

Kymera Therapeutics (KYMR) has reported earnings of -0.95 per share for Q3 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.